 hemolytic-urem syndrom bone marrow transplant adult hematolog malign adult patient b-cell non-hodgkin lymphoma nhl hematolog malign autolog allogen bone marrow transplant bmt subsequ develop hemolytic-urem syndrom hu patient cyclophosphamid total bodi irradi interv first year post-bmt patient uniform measur hematocrit hct serum creatinin sixteen patient hct valu normal rang bmt popul sudden decreas hct creatinin month post-bmt clinic laboratori criteria hu none patient activ cytomegaloviru infect graft-versus-host diseas cyclosporin administr degre decreas hct creatinin elev laboratori abnorm signific syndrom patient acut clinic complic congest heart failur hypertens htn peripher edema patient red blood cell support patient platelet transfus hemolyt anemia thrombocytopenia case mean month postdiagnosi creatinin elev htn patient life-threaten long-term sequela use bmt cur modal patient hematolog malign import patient develop hu potenti long-term impact renal function